42 Stocks Moving In Thursday’s Mid-Day Session
Gainers
American Rebel Holdings, Inc. (NASDAQ: AREB) shares climbed 63.3% to $3.45 following the company's recent uplisting to the Nasdaq.
Recap: TechTarget Q4 Earnings
TechTarget (NASDAQ:TTGT) reported its Q4 earnings results on Thursday, February 10, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell
• Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
TechTarget Expands Purchase Intent Data, Delivers Personalized Interface For Sellers And Marketers In Latest Release Of Priority Engine Platform
TechTarget, Inc. (NASDAQ:TTGT), the global leader in B2B technology purchase intent data and services, today announced that it has enhanced the ability of sales and marketing teams to leverage its proprietary intent
Keybanc Maintains Overweight on TechTarget, Raises Price Target to $115
Keybanc analyst Justin Patterson maintains TechTarget (NASDAQ:TTGT) with a Overweight and raises the price target from $103 to $115.
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
TechTarget Says Acquires Xtelligent Healthcare Media, the Largest Marketing Services, Media and Data Company in B2B Healthcare Technology
Acquisition allows the Company to grow its customer base and significantly expand audience reach, first party intent data and revenues in a key new market
Global technology media and purchase intent-driven marketing and
TechTarget Q2 EPS $0.51 Beats $0.49 Estimate, Sales $63.71M Beat $60.30M Estimate
TechTarget (NASDAQ:TTGT) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.49 by 4.08 percent. This is a 82.14 percent increase over earnings of $0.28 per share from the same
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
